Tilray Brands, Inc. - Common Stock (TLRY)

It will take more than that to make this stock attractive.

Tilray’s third quarter results were met with a strong positive response from the market, reflecting the company's progress in expanding its diversified business model and achieving a notable improvement in operating margin. Management attributed the quarter’s performance to double-digit growth in Canadian adult-use and international cannabis segments, as well as operational improvements across its beverage and wellness divisions. CEO Irwin Simon highlighted that, outside of a flat beverage segment affected by SKU rationalization, all core business lines contributed to revenue growth, with focused efforts on product innovation and efficiency driving the company’s improved profitability.

Yes, the wacky weed has good and positive healthcare uses too.

A Marijuana Moment report cites findings from a new study showing medical cannabis legalization leads to significant reductions in opioid prescriptions.

Companies that burn cash at a rapid pace can run into serious trouble if they fail to secure funding. Without a clear path to profitability, these businesses risk dilution, mounting debt, or even bankruptcy.

Curious about the most active stocks in today's session? Get a glimpse into the stocks that are generating the highest trading volume and capturing market attention.

Temporarily profitable Tilray is taking advantage of its chance to raise some cash.

Tilray Brands shares are trading lower Friday morning, a sharp reversal after the stock hit a new 52-week high on Thursday.

Although artificial intelligence continues to dominate business headlines, Cannabis specialist Tilray provided perhaps a much-needed change of pace.

Cannabis company Tilray Brands (NASDAQ:TLRY) beat Wall Street’s revenue expectations in Q3 CY2025, with sales up 4.7% year on year to $209.5 million. Its non-GAAP loss of $0 per share increased from -$0.04 in the same quarter last year.

Tilray Brands surged after posting stronger-than-expected quarterly results and renewed optimism around U.S. cannabis reform.

While the company regained Nasdaq compliance this quarter, its high float and low institutional ownership mean sentiment can swing fast.

Tilray Brands shares are trading higher Thursday afternoon following the release of a strong first-quarter fiscal 2026 earnings report.

Let's have a look at what is happening on the US markets on Thursday. Below you can find the most active stocks in today's session.

Shares of cannabis company Tilray Brands (NASDAQ:TLRY) jumped 24.9% in the morning session after the company reported third-quarter financial results that topped analyst expectations. 

Tilray surprised marijuana investors once today. Can it do it again?

Tilray stock surges after Q1 earnings beat estimates with break-even results, higher revenue, and improved balance sheet strength.

The session on Thursday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session.

Cannabis company Tilray Brands (NASDAQ:TLRY) reported Q3 CY2025 results beating Wall Street’s revenue expectations, with sales up 4.7% year on year to $209.5 million. Its non-GAAP loss of $0 per share increased from -$0.04 in the same quarter last year.

Tilray Brands returns to profitability in Q1 fiscal 2026, posting record revenue and a positive EPS, driving a strong pre-market stock surge.